Stock Incentive Compensation

Stock Incentive Compensation requires us to expense share-based payment awards granted. Compensation cost for share-based payments transactions are measured at fair value. For stock options, we use the simplified method of calculating the expected term and historical volatility to compute fair value under the Black-Scholes option-pricing model. The risk-free rate for periods within the contractual life of the option is based on the U.S. zero coupon Treasury yield in effect at the time of grant. New restricted stock and restricted stock unit grants are valued at the closing market price of our common stock on the date of grant. We do not estimate a forfeiture rate at the time of grant. Instead, we recognize share-based compensation expense when actual forfeitures occur.

2019 Equity and Incentive Compensation Plan

Long-Term / Annual Incentives

On February 26, 2019, stockholders approved and adopted the 2019 Equity and Incentive Compensation Plan ("2019 Plan" or "Incentive Plan") which replaced the 2016 Equity and Incentive Compensation Plan. The 2019 Plan authorizes the Compensation Committee of the Board of Directors of the Company to grant to officers and other key employees, including directors, of the Company and our subsidiaries (i) stock options, (ii) appreciation rights, (iii) restricted shares, (iv) restricted stock units, (v) cash incentive awards, performance shares and performance units and (vi) other awards. An aggregate of 1,500,000 shares of Common Stock, subject to adjustment upon occurrence of certain events to prevent dilution or expansion of the rights of participants that might otherwise result from the occurrence of such events, was reserved for issuance pursuant to the Incentive Plan. An individual’s award of options and / or appreciation rights is limited to 500,000 shares during any calendar year. Also, an individual's award of restricted shares, restricted share units and performance based awards is limited to 350,000 shares during any calendar year.

The following table summarizes the Company’s Incentive Plan activity for the nine months ended July 31, 2019 and 2018:



	Stock Options				Restricted Stock				Restricted Stock Units
Outstanding at:	Options		Weighted Average Exercise Price	Weighted Average Remaining Contractual Life	Restricted Shares		Grant Fair Value	Weighted Average Remaining Contractual Life	Restricted Share Units		Grant Fair Value	Weighted Average Remaining Contractual Life



November 1, 2017	58		$8.16	2.53	441		$7.07	1.60	36		$7.69	1.82
Granted	—		—		296		8.12		18		7.90
Options exercised or restricted stock vested	(12	)	3.26		(200	)	7.51		(15	)	8.30
Forfeited or expired	(3	)	12.04		(41	)	7.08		(12	)	6.18
July 31, 2018	43		$9.33	1.83	496		$7.52	1.95	26		$8.17	1.72

November 1, 2018	33		$9.42	1.84	478		$7.45	1.87	27		$8.17	1.37
Granted	—		—		418		6.73		42		6.47
Options exercised or restricted stock vested	—		—		(230	)	6.84		(14	)	7.98
Forfeited or expired	—		—		(54	)	7.39		(4	)	7.35
July 31, 2019	33		$9.42	1.09	612		$7.20	1.97	51		$6.84	2.00

We recorded stock compensation expense related to stock options, restricted stock and restricted stock units during the three and nine months ended July 31, 2019 and 2018 as follows:



	Three Months Ended July 31,				Nine Months Ended July 31,
	2019		2018		2019		2018
Restricted stock	$	544	$	488	$	1,461	$	1,465
Restricted stock units	42		27		115		92
Total	$	586	$	515	$	1,576	$	1,557

Stock Options - The exercise price of each stock option equals the market price of our common stock on the grant date. Compensation expense is recorded at the grant date fair value, adjusted for forfeitures as they occur, and is recognized over the applicable vesting periods. Our stock options generally vest over three years, with a maximum term of ten years. Incentive stock options were not granted during the nine months ended July 31, 2019 and 2018.

Cash received from the exercise of options for the nine months ended July 31, 2019 and July 31, 2018 was $0 and $41, respectively. Options that have an exercise price greater than the market price are excluded from the intrinsic value computation. At July 31, 2019 and October 31, 2018, the options outstanding and exercisable had an intrinsic value of $0 and $42, respectively.

Restricted Stock Awards - New restricted stock grants are valued at the closing market price of our common stock on the grant date. Compensation expense is recorded at the grant date fair value, adjusted for forfeitures as they occur and is recognized over the applicable vesting periods. The vesting periods range between one to three years. As of July 31, 2019, there was $3,280 of unrecognized compensation expense related to non-vested restricted stock that is expected to be recognized over the next three fiscal years.

Restricted Stock Units - New restricted stock unit grants are valued at the closing market price of our common stock on the grant date. Compensation expense is recorded at the grant date fair value, adjusted for forfeitures as they occur and is recognized over the applicable vesting periods. The vesting periods range between one to three years. As of July 31, 2019, there was $258 of unrecognized compensation expense related to these restricted stock units that is expected to be recognized over the applicable vesting periods.